# Dexamethasone

## Dexamethasone inj 5mg/1mL

| TAH Drug Code      | [IDEXA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IDEXA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Conditions where the anti-inflammatory & immunosuppressive effects of the corticosteroids are desirable, especially for intensive treatment during shorter periods.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | IM and IV: 2-10 mg (0.4-2 mL). INS : 4-6 mg (0.8-1.2 mL) on large joint and 0.8-1 mg (0.16-0.2 mL) for smaller joint. Soft tissue: 2-6 mg (0.4-1.2 mL). Subconjectival or retrobulbar injection: 0.4-2 mg (0.08-0.4 mL). ID: diluted 1/5 of Dexamethasone with normal saline, then inject 0.1mL. Eye drops: diluted 1/25 of Dexamethasone with normal saline.                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Systemic fungal infection, hypersensitivity. Administration of live virus vaccine, unstable or infected joint, diagnosed sepsis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Adverse Effects    | Common: Body fluid retention, Hypertension, Skin irritation, Cushing's syndrome, Decreased body growth, Depression, Euphoria, Pulmonary tuberculosis Serious: Cardiac rupture due to and following acute myocardial infarction, Cardiomyopathy, Thromboembolic disorder, Hyperglycemia, Pancreatitis, Perforation of large intestine, Perforation of small intestine, Non-allergic anaphylaxis, Compression fracture of vertebral column, Osteoporosis, Cerebrovascular accident, Infarction of spinal cord, Nerve injury, Paraplegia, Raised intracranial pressure, Seizure, Tetraplegia, Blindness AND/OR vision impairment level, Cortical blindness |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

## Dorison 4mg

| TAH Drug Code      | [ODOR4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODOR4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Conditions where the anti-inflammatory and immunosuppressive effects of the corticosteroids are desirable, especially for intensive treatment during shorter periods.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Adult: Usually 4-20 mg/day given QD or in 2-4 divided doses; High dose: 0.4-0.8 mg/kg/day (usually <= 40 mg/day). Pediatric: 0.02-0.6 mg/kg/day given QD or in 2-4 divided doses; MAX 16 mg/day. Cerebral edema: Loading dose: 1-2 mg/kg/dose as a single dose; maintenance: 1-2 mg/kg/day in divided doses Q4-6H; MAX 16 mg/day. Chemotherapy-induced nausea and vomiting, prevention: (Reduce dose by 50% if administered concomitantly with aprepitant) Highly/severely emetogenic chemotherapy: 6 mg/m2/dose Q6H. Moderately emetogenic chemotherapy: BSA <= 0.6 m2: 2mg Q12H; BSA > 0.6 m2: 4mg Q12H. COVID-19 treatment: 0.15-0.3 mg/kg/dose QD for up to 10 days; MAX 6 mg/dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Systemic fungal infection, hypersensitivity. Administration of live virus vaccine, unstable or infected joint, diagnosed sepsis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Common: Hypertension (Diabetic macular edema, 13%), Cushing's syndrome, Decreased body growth, Abnormal vision (1-9%), Cataract (Diabetic macular edema, 68%; retinal vein occlusion and uveitis, 5-54%), Conjunctival edema (5%), Conjunctivitis (6%), Corneal edema (Postoperative ocular inflammation and pain, 1% ; postoperative inflammation, 5-15%), Discomfort, Eye (10%), Disorder of anterior chamber of eye, Inflammation (10%), Dry eye syndrome (5%), Iridocyclitis, Iritis (5-15%), Raised intraocular pressure (Retinal vein occlusion and uveitis, 24-25% ; postoperative inflammation and pain, 5-15% ; ocular itching, 3% i), Vitreous floaters (1-5%), Depression, Euphoria, Pulmonary tuberculosis Serious: Cardiomyopathy, Rupture of ventricle due to acute myocardial infarction, Hyperglycemia, Hypokalemia, Pancreatitis, Infectious disease, Osteoporosis, Conjunctival hemorrhage (Diabetic macular edema, 23%; retinal vein occlusion and uveitis, 22%), Glaucoma (Diabetic macular edema, 1.2%), Keratitis (2%), Posterior subcapsular cataract, Retinal tear (2%), Retinal vascular disorder (3%), Uveitis (2%) |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

